Clinical Features and Genomic Characterization of Post-Colonoscopy Colorectal Cancer

1. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by

colonoscopic polypectomy. The National Polyp Study Workgroup.

N Engl J Med 1993;329:1977–81.

2. Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy

and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;

366:687–96.

3. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy

and death from colorectal cancer. Ann Intern Med 2009;150:1–8.

4. Singh H, Nugent Z, Demers AA, et al. The reduction in colorectal cancer

mortality after colonoscopy varies by site of the cancer. Gastroenterology

2010;139:1128–37.

5. Baxter NN, Warren JL, Barrett MJ, et al. Association between

colonoscopy and colorectal cancer mortality in a US cohort according to

site of cancer and colonoscopist specialty. J Clin Oncol 2012;30:2664–9.

6. Brenner H, Chang-Claude J, Seiler CM, et al. Protection from colorectal

cancer after colonoscopy: A population-based, case-control study. Ann

Intern Med 2011;154:22–30.

7. Jacob BJ, Moineddin R, Sutradhar R, et al. Effect of colonoscopy on

colorectal cancer incidence and mortality: An instrumental variable

analysis. Gastrointest Endosc 2012;76:355–64.

8. Doubeni CA, Corley DA, Quinn VP, et al. Effectiveness of screening

colonoscopy in reducing the risk of death from right and left colon cancer:

A large community-based study. Gut 2018;67:291–8.

9. Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer

incidence and mortality after lower endoscopy. N Engl J Med 2013;369:

1095–105.

10. M¨uller AD, Sonnenberg A. Prevention of colorectal cancer by flexible

endoscopy and polypectomy. A case-control study of 32,702 veterans.

Ann Intern Med 1995;123:904–10.

11. Singh H, Turner D, Xue L, et al. Risk of developing colorectal cancer

following a negative colonoscopy examination: Evidence for a 10-year

interval between colonoscopies. JAMA 2006;295:2366–73.

12. Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for

colonoscopy and the risk of interval cancer. N Engl J Med 2010;362:

1795–803.

13. le Clercq CM, Bouwens MW, Rondagh EJ, et al. Postcolonoscopy

colorectal cancers are preventable: A population-based study. Gut 2014;

63:957–63.

14. Brenner H, Chang-Claude J, Seiler CM, et al. Interval cancers after negative

colonoscopy: Population-based case-control study. Gut 2012;61:1576–82.

15. Ferr´andez A, Navarro M, D´ıez M, et al. Risk factors for advanced lesions

undetected at prior colonoscopy: Not always poor preparation.

Endoscopy 2010;42:1071–6.

16. Farrar WD, Sawhney MS, Nelson DB, et al. Colorectal cancers found after

a complete colonoscopy. Clin Gastroenterol Hepatol 2006;4:1259–64.

17. Lederle Y, Gong W, Su B, et al. Risk and cause of interval colorectal cancer

after colonoscopic polypectomy. Digestion 2012;86:148–54.

18. Cheung D, Evison F, Patel P, et al. Factors associated with colorectal

cancer occurrence after colonoscopy that did not diagnose colorectal

cancer. Gastrointest Endosc 2016;84:287–95.

19. Baxter NN, Sutradhar R, Forbes SS, et al. Analysis of administrative data

finds endoscopist quality measures associated with postcolonoscopy

colorectal cancer. Gastroenterology 2011;140:65–72.

20. Erichsen R, Baron JA, Stoffel EM, et al. Characteristics and survival of

interval and sporadic colorectal cancer patients: A nationwide

population-based cohort study. Am J Gastroenterol 2013;108:1332–40.

21. Bressler B, Paszat LF, Chen Z, et al. Rates of new or missed colorectal

cancers after colonoscopy and their risk factors: A population-based

analysis. Gastroenterology 2007;132:96–102.

22. Singh H, Nugent Z, Mahmud SM, et al. Predictors of colorectal cancer

after negative colonoscopy: A population-based study. Am J

Gastroenterol 2010;105:663–73.

American College of Gastroenterology

23. Stoffel EM, Erichsen R, Frøslev T, et al. Clinical and molecular

characteristics of post-colonoscopy colorectal cancer: A populationbased study. Gastroenterology 2016;151:870–8.

24. Cooper GS, Xu F, Barnholtz Sloan JS, et al. Prevalence and predictors of

interval colorectal cancers in medicare beneficiaries. Cancer 2012;118:

3044–52.

25. Samadder NJ, Curtin K, Tuohy TM, et al. Characteristics of missed or

interval colorectal cancer and patient survival: A population-based study.

Gastroenterology 2014;146:950–60.

26. Sawhney MS, Farrar WD, Gudiseva S, et al. Microsatellite instability in

interval colon cancers. Gastroenterology 2006;131:1700–5.

27. Richter JM, Pino MS, Austin TR, et al. Genetic mechanisms in interval

colon cancers. Dig Dis Sci 2014;59:2255–63.

28. Arain MA, Sawhney M, Sheikh S, et al. CIMP status of interval colon

cancers: Another piece to the puzzle. Am J Gastroenterol 2010;105:

1189–95.

29. Samadder NJ, Neklason D, Snow A, et al. Clinical and molecular features

of post-colonoscopy colorectal cancers. Clin Gastroenterol Hepatol 2019;

17:2731–9.

30. Shaukat A, Arain M, Thaygarajan B, et al. Is BRAF mutation associated

with interval colorectal cancers? Dig Dis Sci 2010;55:2352–6.

31. Japanese Society for Cancer of the Colon and Rectum. Japanese

Classification of Colorectal, Appendiceal, and Anal Carcinomas [in

Japanese]. 9th edn. Tokyo, Japan: Kanehara and Co, 2018.

32. Sobin L, Gospodarowicz MK, Wittekind C. TNM Classification of

Malignant Tumors. 7th edn. Chichester, West Sussex: Wiley-Blackwell,

2010.

33. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during

colorectal-tumor development. N Engl J Med 1988;319:525–32.

34. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer

pathogenesis. Gastroenterology 2010;138:2088–100.

35. Rutter MD, Beintaris I, Valori R, et al. World endoscopy organization

consensus statements on post-colonoscopy and post-imaging colorectal

cancer. Gastroenterology 2018;155:909–25.

36. Hamilton SR, Bosman FT, Boffetta P, et al. Carcinoma of the colon and

rectum. In: Bosman FT, Carneiro F, Hurban RH, et al (eds) WHO

Classification of Tumours of the Digestive System. Lyon, France: IARC

Press, 2010, pp 132–46.

37. Tanaka S, Saitoh Y, Matsuda T, et al. Evidence-based clinical practice

guidelines for management of colorectal polyps. J Gastroenterol 2015;50:

252–60.

38. Ninomiya Y, Oka S, Tanaka S, et al. Clinical impact of surveillance

colonoscopy using magnification without diminutive polyp removal. Dig

Endosc 2017;29:773–81.

39. Tanaka H, Oka S, Tanaka S, et al. Can surveillance colonoscopy be

discontinued in an elderly population with diminutive polyps? J Anus

Rectum Colon 2019;3:128–35.

40. Hotta K, Matsuda T, Tanaka K. Post-polypectomy colonoscopy

surveillance in the real clinical practice: Nationwide survey of 792 board

certified institutions of the Japan Gastroenterological Endoscopy Society.

Dig Endosc 2020;32:824.

41. The Cancer Genome Atlas Network. Comprehensive molecular

characterization of human colon and rectal cancer. Nature 2012;487:

330–7.

42. Colorectal adenocarcinoma (database online). The cancer Genome Atlas,

Pan-cancer Atlas. https://www.cbioportal.org/study/summary?

id5coadread_tcga_pan_can_atlas_2018. Accessed September 13, 2020.

Open Access This is an open access article distributed under the Creative

Commons Attribution License 4.0 (CCBY), which permits unrestricted use,

distribution, and reproduction in any medium, provided the original work is

properly cited.

Clinical and Translational Gastroenterology

COLON

Clinical Features and Genomic Characterization of PCCRCs

...